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278Objective: The biomechanical response to a myocardial infarction consists of ventricular remodeling that leads
to dilatation, loss of contractile function, abnormal stress patterns, and ultimately heart failure. We hypothesized
that intramyocardial injection of our previously designed pro-angiogenic chemokine, an engineered stromal
cell–derived factor-1a analog (ESA), improves mechanical properties of the heart after infarction.
Methods:Male rats (n¼ 54) underwent either sham surgery (n¼ 17) with no coronary artery ligation or ligation
of the left anterior descending artery (n¼ 37). The rats in the myocardial infarction group were then randomized
to receive either saline (0.1 mL, n ¼ 18) or ESA (6 mg/kg, n ¼ 19) injected into the myocardium at 4 predeter-
mined spots around the border zone. Echocardiograms were performed preoperatively and before the terminal
surgery. After 4 weeks, the hearts were explanted and longitudinally sectioned. Uniaxial tensile testing was com-
pleted using an Instron 5543Microtester. Optical strain was evaluated using custom image acquisition software,
Digi-Velpo, and analyzed in MATLAB.
Results:Compared with the saline control group at 4 weeks, the ESA-injected hearts had a greater ejection frac-
tion (71.8%  9.0% vs 55.3%  12.6%, P ¼ .0004), smaller end-diastolic left ventricular internal dimension
(0.686  0.110 cm vs 0.763  0.160 cm, P ¼ .04), greater cardiac output (36  11.6 mL/min vs 26.9  7.3
mL/min, P ¼ .05), and a lower tensile modulus (251  56 kPa vs 301  81 kPa, P ¼ .04). The tensile modulus
for the sham group was 195  56 kPa, indicating ESA injection results in a less stiff ventricle.
Conclusions:Direct injection of ESA alters the biomechanical response to myocardial infarction, improving the
mechanical properties in the postinfarct heart. (J Thorac Cardiovasc Surg 2013;145:278-84)The tissue response to a myocardial infarction (MI) entails
far more than the simple conversion of muscle into a hypo-
contractile scar. Significant interplay also occurs between
the ischemic and healthy myocardium. Previous studies
have effectively shown that a perfused, yet hypocontractile,
border zone is present around the area of anMI and that over
time this border zone expands to include previously healthy
tissue.1 In response to this border zone expansion, ventric-
ular remodeling occurs, including collagen deposition,e Division of Cardiovascular Surgery,a Department of Surgery, University of
ylvania School of Medicine, Philadelphia, Pa; and the Penn Center for Mus-
keletal Disorders,b University of Pennsylvania, Philadelphia, Pa.
ork was supported in part by National Institutes of Health grant
HL089315-01 (to Y.J.W.), National Institutes of Health grant T32
7843-15 (to J.W.M.), and American Heart Association Post Doctoral Fellow-
rant 12POST11620024 (to J.W.M.).
res: Authors have nothing to disclose with regard to commercial support.
the 38th Annual Meeting of The Western Thoracic Surgical Association,
, Hawaii, June 27-30, 2012.
d for publication June 26, 2012; revisions received Aug 29, 2012; accepted
blication Sept 12, 2012.
for reprints: Y. Joseph Woo, MD, Division of Cardiovascular Surgery,
rtment of Surgery, University of Pennsylvania School of Medicine, 3400
e St, 6 Silverstein, Philadelphia, PA 19104 (E-mail: wooy@uphs.upenn.edu).
23/$36.00
ht  2013 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2012.09.080
The Journal of Thoracic and Cardiovascular Surgscar formation, myocyte apoptosis, and progressive dila-
tion.2 All these characteristics lead to mechanical ineffi-
ciency of the ventricle, altered regional stress-strain
patterns, and ultimately heart failure, accounting for signif-
icant morbidity and mortality.
In an effort to preserve ventricular mechanical properties
and prevent the adverse effects associated with remodeling,
it would be appealing to institute therapy aimed at limiting
the extent of border zone expansion. The endothelial pro-
genitor stem cell cytokine, stromal cell–derived factor-1a
(SDF), has been shown by our group and others to increase
neovascularity, decrease border zone expansion, decrease
cardiac myocyte apoptosis, and increase cardiac myocyte
survival.3-6 We have engineered a mathematically de-
signed, supra-efficient analog of SDF—engineered stromal
cell–derived factor-1a stem cell cytokine (ESA)—and dem-
onstrated its in vitro and in vivo potency.7,8
Many groups have studied the mechanical properties of
ventricular myocardium in various animal models and
have shown that infarcts become stiffer over time.9-11 To
our knowledge, no group has tested the mechanical effect
an infarct has on the ventricle as a whole by evaluating
the infarct, border zone, and remote tissue simultaneously.
In the present study, we hypothesized that intramyocardialery c January 2013
Abbreviations and Acronyms
ESA ¼ engineered stromal cell–derived factor-1a
analog
MI ¼ myocardial infarction
SDF ¼ stromal cell–derived factor-1a
MacArthur et al Evolving Technology/Basic Scienceinjection of ESA at the time of MI would limit the amount
of ventricular remodeling and preserve the myocardial
mechanical properties, leading to more favorable regional
stress-strain patterns. We postulated that studying the ten-
sile properties of ventricular muscle strips would yield valu-
able data and insight into how the infarct affects the remote
myocardium.E
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Protein Design and Synthesis
We have previously reported on the design and synthesis of ESA.7 In
brief, the CXCR4 receptor binding N-terminus and the molecular-
stabilizing C-terminus were preserved and the central b-pleated sheet
was deleted and replaced with 2 proline residues mathematically predicted
to retain as similar a 3-dimensional protein configuration to the native SDF
as possible. The designed protein was synthesized using solid phase pep-
tide synthesis in which the N a-amino acids are incorporated into the pep-
tide in a stepwise fashion while the terminus is attached to a solid support
matrix. After the peptide is complete, it is removed from the polymeric sup-
port matrix and lyophilized.
Animal Care and Biosafety
Male Wistar rats, weighing 250 to 300 g were obtained from Charles
River Labs (Wilmington, Mass). Food and water were provided ad lib.
All experiments pertaining to the present investigation conformed to the
Guide for the Care and Use of Laboratory Animals, published by the US
National Institutes of Health (8th edition, 2011). The Institutional Animal
Use and Care Committee of the University of Pennsylvania approved the
protocol (no. 803394).
Animal Model
MI was induced in 37 male Wistar rats using an established and highly
reproducible model.5,6 In brief, the rats were anesthetized in a 2L induction
chamber (VetEquip, Pleasantville, Calif), and 3% isofluorane was
continuously delivered. A 16-gauge angiocatheter was used for endotra-
cheal intubation and connected to mechanical ventilation (Hallowell;
EMC, Pittsfield,Mass), with 1% isofluoranemaintained throughout the op-
eration. A thoracotomy was performed through the left fourth intercostal
space, the heart was exposed, and a 7-0 polypropylene suture was placed
around the left anterior descending artery 2 mm below the left atrium.
The suture was briefly snared to verify the size and location of myocardial
ischemia according to color changes and permanently tied down to produce
a large anterolateral MI. The rats were then randomized into 2 groups and
received 4 separate peri-infarct intramyocardial injections of saline (100
mL, n ¼ 18) or ESA (6 mg/kg, n ¼ 19). In an additional control group,
the rats underwent a sham operation, in which thoracotomywas performed,
as above, but no myocardial ischemia was induced (n¼ 17). The thoracot-
omywas closed in multiple layers, and tissue adhesive (VetBond; 3M,Min-
neapolis, Minn) was applied over the incision. All rats were implanted with
subcutaneous microchips (BioMedic Data Systems; Boise, Idaho) and al-
lowed to recover from anesthesia. Buprenorphine (0.5 mg/kg) was admin-
istered for postoperative pain control. All 3 groups of rats (sham, saline,The Journal of Thoracic and Caand ESA) received subcutaneous injections of granulocyte colony-
stimulating factor (40 mg/kg) immediately postoperatively.
Echocardiographic and Hemodynamic Assessment
Left ventricular (LV) geometry and function were evaluated preopera-
tively and at 4 weeks in all rats. A Phillips Sonos 5500 revD ultrasound sys-
tem (Philips Medical Systems, Amsterdam, The Netherlands) was used,
with a 12-MHz transducer at an image depth of 2 cm. Parasternal LV short
axis 2-dimensional andM-mode images at the level of the papillary muscle
were used to obtain echocardiographic data.12 All analyses were performed
by a single investigator, who was unaware of the treatment groups.
Cardiac output was assessed by placing a 2.5-mm periaortic Doppler
flow probe (Transonic Systems, Ithaca, NY) around the ascending aorta
at the terminal surgery.
Infarct Analysis
At 4 weeks after the initial operation, the rats were anesthetized and un-
derwent median sternotomy. After the echocardiographic and hemody-
namic data had been obtained, the rats were euthanized and the hearts
explanted. The atria were removed, and the left ventricle was opened along
the posterior septum. Standardized digital photographs were taken with
a Nikon D5100 SLR camera (Nikon, Tokyo, Japan). The photographs
were uploaded to ImageJ (version 1.46b), and the size of the infarct was
assessed with digital planimetry.
In a subset of 9 rats, the hearts were explanted (2 in sham, 3 in saline,
and 4 in ESA group) and injected retrograde with Tissue Tek OCT com-
pound (Sekura, The Netherlands) through the aorta and pulmonary artery.
The hearts were submerged in OCT, frozen, and stored in a80C freezer.
The orientation of the hearts during freezing was standardized to result in
consistent positioning during the sectioning process. Eight, 10-mm-thick
sections were prepared from each heart at the level of the papillary muscles
and stained with hematoxylin and eosin or Masson’s trichrome stain. Pho-
tographs of the border zone were taken using a Leica DFC295 inverted mi-
croscope (Leica Microsystems, Wetzlar, Germany) using the 203
objective. The images were analyzed for infarct collagen content, which
turns blue after Masson’s trichrome staining, using a custom-made macro
in ImageJ.
Mechanical Testing of Ventricular Muscle Strips
A 15 mm 3 3 mm strip of myocardium was excised from the left
ventricle, taken in line with the force vector from apex to base
(Figure 1). Polytetrafluoroethylene pledgets were sutured to the ends of
the strip with 7-0 polypropylene sutures, and a looped suture was passed
through these pledgets to provide a method to mount the specimens
(Figure 2). The strips were then placed in a temperature-regulated bath
of phosphate-buffered saline maintained at 37C. Uniaxial tensile testing
was conducted with an Instron 5543 microtester (Instron, Norwood,
Mass) with a 10 N, 6-axis load cell (Figure 3). The specimens were pre-
loaded at 0.05 N, followed by 20 cycles of preconditioning at a rate of
0.1 mm/s and a load ranging from 0.05 to 0.1 N. After a 60-s hold at
0.05 N, 3 stress-relaxation phases at incremental displacements of
0.5 mm were performed, followed by a ramp to failure at 0.1 mm/s. A cus-
tom image acquisition software system (Digi-Velpo, version 1.4.1, run in
LabView 2010, National Instruments, Austin, Tex) was used to acquire op-
tical data on tissue displacement. Optical strain data were integrated with
the Instron load data using Opticus (custom-made software run in MAT-
LAB, Natick, Mass), which generated stress-strain curves for each ventric-
ular strip.
Statistical Analysis
Continuous variables are reported as the mean  standard deviation.
Student t test was used to compare continuous variables. The study was de-
signedwith 80% power to detect a 10% difference in tensile modulus, withrdiovascular Surgery c Volume 145, Number 1 279
FIGURE 1. Ventricles were opened along the posterior free wall, adjacent
to the septum and longitudinally sectioned (white hash marks) for tensile
testing.
FIGURE 3. Image of ventricular strip inside the temperature-regulated
bath, connected to the Instron microtester (Instron, Norwood, Mass).
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Sa standard deviation of 50 kPa, requiring 15 animals per group. Statistical
significance was set at P< .05. The analyses were performed using the
STATA statistical software package, version 12.1 (StataCorp, College Sta-
tion, Tex).
RESULTS
Infarct Size and Content
After 4 weeks, the saline and ESA groups had statisti-
cally equivalent infarct sizes (saline control, 23.9% 
6.1%; ESA, 20.4%  2.8%; P ¼ .1), supporting the re-
producibility of this infarct model and consistency be-
tween the experimental and control groups. As expected,
no infarcts were visualized in the sham group (Figures 4
and 5). The collagen content within the infarct wasFIGURE 2. Ventricular strip with custom-made polytetrafluoroethylene
pledgets reinforcing the edges.
280 The Journal of Thoracic and Cardiovascular Surgsignificantly greater in the saline group than in the ESA
group (saline control, 38.6%  9.4%; ESA, 30.8% 
5.7%; P ¼ .01; Figure 6).Ventricular Remodeling and Function
The preoperative echocardiographic parameters were
not statistically different among the 3 different groups.
During the course of 4 weeks, LV dilation occurred in
both the ESA and the saline control groups. The saline
control group had a statistically significant increase in
the LV internal dimension at diastole (0.763  0.160
cm) compared with that in the ESA group (0.686 
0.110 cm, P ¼ .04) and sham group (0.539  0.135
cm, P ¼ .0004). As expected with the normal growth
of the rat within 4 weeks, a minimal increase was found
in the LV internal dimension at diastole of the sham
group and the ejection fraction had improved slightly
(82.5%  7.5%). In contrast, in the saline control
group, the ejection fraction had decreased significantly
during the 4-week course (55.3%  12.6%), but that
in the ESA group was preserved and closer to the preop-
erative value (71.8%  9.0%; Figure 7). Additionally,
a significant decline was seen in the cardiac output of
the saline control group (26.9  7.3 mL/min), although
the level in the ESA group approached that of the
sham group (36  11.6 mL/min and 37  7.3 mL/min,
respectively) (Table 1).Myocardial Mechanical Properties
The percentage of relaxation was determined from the
stress-relaxation cycles obtained during mechanical test-
ing, and no statistically significant differences were found
among the 3 groups (sham, 36.4%  10.7%; saline con-
trol, 38.3%  4.6%; and ESA, 38.2%  4.4%). Finally,
the tensile modulus was calculated from the slope of theery c January 2013
FIGURE 4. Representative images of infarct sizes. A, Sham operated group, (B) saline control group, and (C) engineered stromal cell–derived factor-1a
analog experimental (ESA) group. Although overall scar area was similar between saline control and ESA groups, it appears that the quality of the scar was
different.
MacArthur et al Evolving Technology/Basic Sciencestress-strain curves and was found to be significantly
greater in the saline control group (300.8  81.6 kPa)
than in the ESA group (251.5  56.7 kPa; P ¼ .04). In
contrast, the sham group had a modulus of 195.2  56.5
kPa (Figure 7).
DISCUSSION
The detrimental effects of border zone expansion on the
mechanical properties of the ventricle are well known, and
different materials have been delivered intramyocardially in
an effort to limit this expansion.13-15 Improvements in
cardiac function, along with increased vascularity in the
border zone, have been shown with various growth factor
and cytokine injections.7,8,16-19 Our group has specifically
shown that the computationally derived, synthesized
cytokine ESA is a potent chemokine of bone marrow
progenitor cells and is efficacious at preserving
ventricular hemodynamics after MI in an animal model7;
however, the effects any of these treatments have on theFIGURE 5. Representative cross-sectional images of hematoxylin and eosin–st
ESA group.
The Journal of Thoracic and Camechanical properties of the global ventricle after infarc-
tion are not known.
In the present study, we have shown that injection of ESA
into the border zone at MI, not only preserves ventricular
function over time, but also leads to an infarct with less col-
lagen and a ventricle with a lower elastic modulus. The his-
tologic analysis leads us to believe that treatment with ESA
causes a change in composition of the extracellular matrix
within the infarcted myocardium, a finding that might ex-
plain the decreased elastic modulus seen in the ESA group
compared with the saline control group. Another factor that
could potentially explain the change in tensile properties
among the groups is elastin content within the extracellular
matrix. In a recent study by Li and colleagues,20 rats in-
jected with bone marrow stromal cells transfected with
the human elastin gene were effectively shown to preserve
ventricular function, reduce scar thickness, and stabilize in-
farcts without expansion, improvements attributed to over-
expression of elastin. Although we did not specificallyained section of ventricles from (A) sham group, (B) saline control, and (C)
rdiovascular Surgery c Volume 145, Number 1 281
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FIGURE 6. Representative cross-sectional images ofMasson’s trichrome–stained sections of ventricles from (A) sham group, (B) saline control group, and
(C) ESA group. On analysis under 203 objective, infarcts in the ESA group had significantly less collagen than in the saline control group (ESA group,
30.8%  5.7%; saline control, 38.6%; P ¼ .01).
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Sevaluate this, it is possible that in the ESA group, bone mar-
row progenitor cells homed to the ischemic myocardium,
preserving the extracellular matrix components and elastin
content. Kaushal and colleagues21 showed in a study ofFIGURE 7. A, Ejection fraction and (B) tensile modulus of the different
groups. *P<.05. ESA, Engineered stromal cell–derived factor-1a analog;
LAD, left anterior descending (artery); MI, myocardial infarction; Pre-op,
preoperative.
282 The Journal of Thoracic and Cardiovascular Surgtissue-engineered, small-caliber blood vessels using endo-
thelial progenitor stem cells, in which grafts seeded with en-
dothelial progenitor stem cells demonstrated preservation
of the extracellular matrix, specifically the elastin content.
In contrast to many investigations that have studied
specified regions of the ventricle,9,15,22,23 we used
longitudinal ventricular strips to assess the uniaxial
tensile properties encompassing the scar, border zone,
and remote tissue in aggregate to understand the stress-
strain relationship of the entire ventricle. The results we
have reported in the present study correlate well with pre-
vious ESA experiments, showing a smaller, less-dilated left
ventricle, greater ejection fraction and greater cardiac out-
put compared with the saline control group.8 One unique
finding from the present study is that treatment with ESA
decreased the elastic modulus of the ventricular strip,
which can be extrapolated to suggest the entire ventricle
is less stiff and similar mechanically to the normal myocar-
dium. These data support our hypothesis that ESA im-
proves the mechanical properties and limits remodeling
of the ventricle after infarction. We believe that treatment
with ESA preserves ventricular geometry and perfusion,
which is inextricably tied to pump efficiency. It is this find-
ing that is of paramount importance in understanding how
to optimize the treatment strategy for ischemic heart
failure.
The fundamental goal of the present study was to
show that injection of ESA improves the mechanics of
the postinfarct ventricle. However, also of great impor-
tance is the myocyte cellular dynamics occurring at a mo-
lecular level between the scar, border zone, and remote
myocardium. The data we have reported indirectly sup-
port that of other investigations in which injected SDF
has been shown to improve the molecular dynamics of
the border zone and preserve ventricular function after
MI.7,24-26ery c January 2013
TABLE 1. Mechanical and hemodynamic results
Variable LVIDd (cm) EF (%) Cardiac output (mL/min) Elastic modulus
Preoperative 0.452  0.090 75.0  8.7 — —
Sham, no infarction (n ¼ 17) 0.539  0.135 82.5  7.5 37.0  7.3 195.2  56.5 (n ¼ 15)
LAD ligation, saline injection
(n ¼ 18)
0.763  0.160 55.3  12.6 26.9  7.3 300.8  81.6 (n ¼ 15)
LAD ligation, ESA injection
(n ¼ 19)
0.686  0.110; P ¼ .04* 71.8  9.0; P ¼ .0004* 36.0  11.6; P ¼ .05* 251.5  56.7 (n ¼ 15); P ¼ .04*
EF, Ejection fraction; ESA, engineered stromal cell–derived factor-1a analog; LAD, left anterior descending (artery); LVIDd, left ventricular internal dimension at diastole. *Com-
pared with saline control group.
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reduction in the elastic modulus of the ventricular
strips treated with ESA, with good confidence intervals
for each specimen sampled, our study had some limita-
tions. First, our technique for obtaining the stress-strain
relationships was through uniaxial testing from longitu-
dinally sectioned ventricle. This leaves out the circum-
ferential strain, which is also important to consider
when determining the overall elastic modulus of the
tissue. An additional shortcoming of uniaxial testing is
its inability to characterize the material properties as
either isotropic or anisotropic. This will be solved by
performing biaxial testing on the strips. The second
limitation we have identified is that the myocyte direc-
tionality was not determined before testing was per-
formed. If alignment of myocytes within a sample
was known, the theoretical modulus of the tissue could
have been obtained. However, we sectioned the ventric-
ular strips to be in line with the summative force vector
of the ventricle, which was standardized across all
groups.
In conclusion, improvements in the mechanical proper-
ties and reduced remodeling of the ventricle can be
achieved with ESA therapy after MI, resulting in improved
hemodynamics. The effects of ESA on the ventricle are
multifactorial and likely a result of limiting expansion of
the border zone, preserving the extracellular matrix within
the infarct, and optimizing the remaining normal
myocardium.
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